232 related articles for article (PubMed ID: 21551278)
1. Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats.
Pires PW; Rogers CT; McClain JL; Garver HS; Fink GD; Dorrance AM
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H87-97. PubMed ID: 21551278
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats.
Rigsby CS; Pollock DM; Dorrance AM
Microvasc Res; 2007 May; 73(3):198-205. PubMed ID: 17250855
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-α inhibition attenuates middle cerebral artery remodeling but increases cerebral ischemic damage in hypertensive rats.
Pires PW; Girgla SS; Moreno G; McClain JL; Dorrance AM
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H658-69. PubMed ID: 25015967
[TBL] [Abstract][Full Text] [Related]
4. Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension.
Rigsby CS; Ergul A; Portik Dobos V; Pollock DM; Dorrance AM
Am J Hypertens; 2011 Jun; 24(6):708-15. PubMed ID: 21350432
[TBL] [Abstract][Full Text] [Related]
5. Focal Ischemic Injury with Complex Middle Cerebral Artery in Stroke-Prone Spontaneously Hypertensive Rats with Loss-Of-Function in NADPH Oxidases.
Yao H; Ferdaus MZ; Zahid HM; Ohara H; Nakahara T; Nabika T
PLoS One; 2015; 10(9):e0138551. PubMed ID: 26389812
[TBL] [Abstract][Full Text] [Related]
6. Improvement in middle cerebral artery structure and endothelial function in stroke-prone spontaneously hypertensive rats after macrophage depletion.
Pires PW; Girgla SS; McClain JL; Kaminski NE; van Rooijen N; Dorrance AM
Microcirculation; 2013 Oct; 20(7):650-61. PubMed ID: 23647512
[TBL] [Abstract][Full Text] [Related]
7. Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists.
Rigsby CS; Burch AE; Ogbi S; Pollock DM; Dorrance AM
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1754-63. PubMed ID: 17670862
[TBL] [Abstract][Full Text] [Related]
8. A high-potassium diet reduces infarct size and improves vascular structure in hypertensive rats.
Dorrance AM; Pollock DM; Romanko OP; Stepp DW
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R415-22. PubMed ID: 16917016
[TBL] [Abstract][Full Text] [Related]
9. Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats.
Intengan HD; Schiffrin EL
Hypertension; 2000 Jun; 35(6):1221-5. PubMed ID: 10856267
[TBL] [Abstract][Full Text] [Related]
10. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
Dunn KM; Renic M; Flasch AK; Harder DR; Falck J; Roman RJ
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2455-65. PubMed ID: 18952718
[TBL] [Abstract][Full Text] [Related]
11. Tempol, a superoxide dismutase mimetic, prevents cerebral vessel remodeling in hypertensive rats.
Pires PW; Deutsch C; McClain JL; Rogers CT; Dorrance AM
Microvasc Res; 2010 Dec; 80(3):445-52. PubMed ID: 20600163
[TBL] [Abstract][Full Text] [Related]
12. Myogenic and structural properties of cerebral arteries from the stroke-prone spontaneously hypertensive rat.
Izzard AS; Graham D; Burnham MP; Heerkens EH; Dominiczak AF; Heagerty AM
Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1489-94. PubMed ID: 12816753
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats.
Dorrance AM; Osborn HL; Grekin R; Webb RC
Am J Physiol Regul Integr Comp Physiol; 2001 Sep; 281(3):R944-50. PubMed ID: 11507012
[TBL] [Abstract][Full Text] [Related]
14. Congenic removal of a QTL for blood pressure attenuates infarct size produced by middle cerebral artery occlusion in hypertensive rats.
Yao H; Cui ZH; Masuda J; Nabika T
Physiol Genomics; 2007 Jun; 30(1):69-73. PubMed ID: 17327494
[TBL] [Abstract][Full Text] [Related]
15. Stroke-prone spontaneously hypertensive rats lose their ability to auto-regulate cerebral blood flow prior to stroke.
Smeda JS; VanVliet BN; King SR
J Hypertens; 1999 Dec; 17(12 Pt 1):1697-705. PubMed ID: 10658935
[TBL] [Abstract][Full Text] [Related]
16. Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor.
Pires PW; Jackson WF; Dorrance AM
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H127-36. PubMed ID: 25910805
[TBL] [Abstract][Full Text] [Related]
17. The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
Ueno M; Wu B; Nishiyama A; Huang CL; Hosomi N; Kusaka T; Nakagawa T; Onodera M; Kido M; Sakamoto H
Hypertens Res; 2009 May; 32(5):332-8. PubMed ID: 19300451
[TBL] [Abstract][Full Text] [Related]
18. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
20. Suppressive action of docosahexaenoic acid enriched-Euglena on reduction of endothelium-dependent relaxation in stroke-prone spontaneously hypertensive rats (SHRSP).
Murakami T; Ogawa H; Hayashi M; Yoshizumi H
J Nutr Sci Vitaminol (Tokyo); 1997 Apr; 43(2):211-23. PubMed ID: 9219094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
